GLANDNSEGland Pharma LimitedMinimalNeutral
Announced Sat, 16 May · 11:25 IST

Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+20.4%1-day move
₹1857.00
prior close
₹2122.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.3-1.5-0.4-0.8+20.4+19.3+25.9+25.2+25.5+24.4+23.2+18.5+32.4
Up moveDown movePending
AI summary

Gland Pharma Limited has published newspaper advertisements informing about its audited financial results for FY26 (year ended March 31, 2026). The Board of Directors approved the results on May 15, 2026, which include both standalone and consolidated financial statements. The statutory audit was conducted by Deloitte Haskins & Sells. The company has published the results in both English and Telugu newspapers as per SEBI Listing Regulations. The full detailed financial results are available on the company's website and stock exchange websites.

Likely market impact

This is a routine regulatory filing confirming FY26 annual results have been formally published. The actual financial numbers are not included in this announcement. Investors should refer to the complete results on the BSE/NSE websites or company investor page for detailed performance metrics.